106 research outputs found
Investigat ing the effect of surface water – groundwater interactions on stream temperature using D istributed Temperature Sensing and instream temperature model
Electrochemical degradation of C.I. Reactive Orange 107 using Gadolinium (Gd3+), Neodymium (Nd3+) and Samarium (Sm3+) doped cerium oxide nanoparticles
Strategies, Practices, and Challenges for Interagency Co-Authorship in an International Science and Development Program
No abstract availabl
Modified cassava starches as potential corrosion inhibitors for sustainable development
Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study
Purpose Delirium is a neuropsychiatric disorder delineated by an acute change in cognition, attention, and consciousness. It is common, particularly in older adults, but poorly recognised. Frailty is the accumulation of deficits conferring an increased risk of adverse outcomes. We set out to determine how severity of frailty, as measured using the CFS, affected delirium rates, and recognition in hospitalised older people in the United Kingdom. Methods Adults over 65 years were included in an observational multi-centre audit across UK hospitals, two prospective rounds, and one retrospective note review. Clinical Frailty Scale (CFS), delirium status, and 30-day outcomes were recorded. Results The overall prevalence of delirium was 16.3% (483). Patients with delirium were more frail than patients without delirium (median CFS 6 vs 4). The risk of delirium was greater with increasing frailty [OR 2.9 (1.8–4.6) in CFS 4 vs 1–3; OR 12.4 (6.2–24.5) in CFS 8 vs 1–3]. Higher CFS was associated with reduced recognition of delirium (OR of 0.7 (0.3–1.9) in CFS 4 compared to 0.2 (0.1–0.7) in CFS 8). These risks were both independent of age and dementia. Conclusion We have demonstrated an incremental increase in risk of delirium with increasing frailty. This has important clinical implications, suggesting that frailty may provide a more nuanced measure of vulnerability to delirium and poor outcomes. However, the most frail patients are least likely to have their delirium diagnosed and there is a significant lack of research into the underlying pathophysiology of both of these common geriatric syndromes
Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study
Purpose:
Delirium is a neuropsychiatric disorder delineated by an acute change in cognition, attention, and consciousness. It is common, particularly in older adults, but poorly recognised. Frailty is the accumulation of deficits conferring an increased risk of adverse outcomes. We set out to determine how severity of frailty, as measured using the CFS, affected delirium rates, and recognition in hospitalised older people in the United Kingdom.
Methods:
Adults over 65 years were included in an observational multi-centre audit across UK hospitals, two prospective rounds, and one retrospective note review. Clinical Frailty Scale (CFS), delirium status, and 30-day outcomes were recorded.
Results:
The overall prevalence of delirium was 16.3% (483). Patients with delirium were more frail than patients without delirium (median CFS 6 vs 4). The risk of delirium was greater with increasing frailty [OR 2.9 (1.8–4.6) in CFS 4 vs 1–3; OR 12.4 (6.2–24.5) in CFS 8 vs 1–3]. Higher CFS was associated with reduced recognition of delirium (OR of 0.7 (0.3–1.9) in CFS 4 compared to 0.2 (0.1–0.7) in CFS 8). These risks were both independent of age and dementia.
Conclusion:
We have demonstrated an incremental increase in risk of delirium with increasing frailty. This has important clinical implications, suggesting that frailty may provide a more nuanced measure of vulnerability to delirium and poor outcomes. However, the most frail patients are least likely to have their delirium diagnosed and there is a significant lack of research into the underlying pathophysiology of both of these common geriatric syndromes
Destruction of methylene blue by mediated electrolysis using two-phase system
The destruction and colour removal of methylene blue were carried out by mediated electrochemical oxidation using
cerium(IV) mediator in nitric acid medium using two-phase system and was applied for oxidation of organic compound.
Organic compounds and mediator were taken in the organic and aqueous phases respectively. The influence
of organic solvent type, cerium(III) concentration, dye concentration, stirring speed and temperature were investigated
in order to find the optimum conditions of the system to check the removal of COD and colour in the organic
phase. The decolourisation followed the pseudo-first order reaction for electrochemically oxidized cerium(IV). The
maximum colour removal efficiency of 95% was achieved within 45 min in dichloromethane solvent system. The
COD removal efficiency and colour removal rate were increased with increase in temperature and stirring speed
Spiny amaranth leaf extract mediated iron oxide nanoparticles: Biocidal photocatalytic propensity, stability, dissolubility and reusability
Comparison of treatment and energy efficiency of advanced oxidation processes for the distillery wastewater
- …
